Plasma lipidomic analysis shows a disease progression signature in mdx mice
Abstract Duchenne muscular dystrophy (DMD) is a rare genetic disorder affecting paediatric patients. The disease course is characterized by loss of muscle mass, which is rapidly substituted by fibrotic and adipose tissue. Clinical and preclinical models have clarified the processes leading to muscle...
Main Authors: | Roula Tsonaka, Alexandre Seyer, Annemieke Aartsma-Rus, Pietro Spitali |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-92406-6 |
Similar Items
-
Multiomic characterization of disease progression in mice lacking dystrophin.
by: Mirko Signorelli, et al.
Published: (2023-01-01) -
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice
by: Flavien Bizot, et al.
Published: (2022-12-01) -
Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
by: Annemieke Aartsma-Rus
Published: (2022-12-01) -
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients
by: Mirko Signorelli, et al.
Published: (2021-04-01) -
Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy
by: Sarah Engelbeen, et al.
Published: (2021-01-01)